Textiles Press Releases
SEE OTHER BRANDS

Your best source on the textile industry news from the world

Textiles Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.

Press releases published on May 7, 2025

Veeco Reports First Quarter 2025 Financial Results

Veeco Reports First Quarter 2025 Financial Results

First Quarter 2025 Highlights: Revenue of $167.3 million, compared with $174.5 million in the same period last year GAAP net income of $11.9 million, or $0.20 per diluted share, compared with $21.9 million, or $0.37 per diluted share in the same period …

Euro Sun Mining Advancing Rovina Valley Project Following Strategic EU Designation

Euro Sun Mining Advancing Rovina Valley Project Following Strategic EU Designation

Euro Sun Mining Advancing Rovina Valley Project Following Strategic EU Designation TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Euro Sun Mining Inc. (TSX: ESM) ("Euro Sun" or the "Company") is pleased to report continued progress on its Rovina Valley Project …

A-Mark Precious Metals Reports Fiscal Third Quarter 2025 Results

A-Mark Precious Metals Reports Fiscal Third Quarter 2025 Results

Q3 FY 2025 Net Loss of $8.5 Million and Q3 YTD FY 2025 Net Income of $7.0 Million Non-GAAP Adjusted Net Income of $5.7 Million and Non-GAAP EBITDA of $1.3 Million in Q3 FY 2025 Q3 FY 2025 Diluted Loss per Share of ($.36) and Q3 YTD FY 2025 Diluted Earnings …

Century Aluminum Company Reports First Quarter 2025 Results

Century Aluminum Company Reports First Quarter 2025 Results

CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its first quarter 2025 results. First Quarter 2025 Financial Results $MM (except shipments and per share data)   Q1 2025   Q4 2024   Aluminum shipments ( …

Silvaco Reports First Quarter 2025 Financial Results

Silvaco Reports First Quarter 2025 Financial Results

Achieved gross bookings of $13.7 million and revenue of $14.1 million in the first quarter 2025 Signed 9 new customers in the first quarter 2025 and expanded relationship with existing customers across key markets including AI, Photonics, and IoT Expanded …

ACV Announces First Quarter 2025 Results

ACV Announces First Quarter 2025 Results

Strong Revenue Growth with Adjusted EBITDA Exceeding High-End of Guidance Reiterates 2025 Guidance First quarter revenue of $183 million First quarter GAAP net income (loss) of ($15) million First quarter non-GAAP net income of $7 million First quarter …

Q3 2025 Results: Lesaka delivers on guidance, reaffirms FY2025 outlook and projects positive net income in FY2026

Q3 2025 Results: Lesaka delivers on guidance, reaffirms FY2025 outlook and projects positive net income in FY2026

JOHANNESBURG, May 07, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the third quarter of fiscal 2025 (“Q3 2025”). Q3 2025 performance: Revenue of $135.7 million (ZAR 2.5 billion) was at the midpoint …

Texas Capital Announces Expansion of Corporate and Investment Banking Division

Texas Capital Announces Expansion of Corporate and Investment Banking Division

DALLAS, May 07, 2025 (GLOBE NEWSWIRE) -- Texas Capital Securities, a subsidiary of Texas Capital Bancshares, Inc. (NASDAQ: TCBI), today announced a significant expansion of the services offered by its Corporate and Investment Bank. The additions to …

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance

WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first …

Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update

Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update

—  Second quarter fiscal 2025 revenue increased 4.4% to $124.3 million —  Year-to-date fiscal 2025 revenue declined 4.1% to $244.2 million —  Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- Inotiv, …

Teekay Corporation Ltd. First Quarter 2025 Business Update; and Declares a Special Dividend

Teekay Corporation Ltd. First Quarter 2025 Business Update; and Declares a Special Dividend

HAMILTON, Bermuda, May 07, 2025 (GLOBE NEWSWIRE) -- Teekay Corporation Ltd. (Teekay or the Company) (NYSE:TK) today reported a business update for the three months ended March 31, 2025. The business update and Teekay Group’s earnings presentation are …

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Interim Data from Low Dose Cohort in MyPEAKTM-1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History and Seroprevalence Study Highlights …

Magnite Reports First Quarter 2025 Results

Magnite Reports First Quarter 2025 Results

Contribution ex-TAC(1) Grows 12% Year-Over-Year Contribution ex-TAC(1) from CTV Grows 15% Year-Over-Year Adjusted EBITDA(1) Grows 47% Year-Over-Year NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the largest independent sell-side …

Emergent BioSolutions Reports First Quarter 2025 Financial Results

Emergent BioSolutions Reports First Quarter 2025 Financial Results

First Quarter 2025 Total Revenues of $222.2 million, decrease of 26% versus prior year First Quarter 2025 Net Income of $68.0 million, increase of 656% versus prior year First Quarter 2025 Gross Margin % of 50% and Adjusted Gross Margin % of 58%, an …

electroCore Announces First Quarter 2025 Financial Results

electroCore Announces First Quarter 2025 Financial Results

First quarter 2025 net sales of $6.7 million, an increase of 23% over first quarter 2024 Closed the acquisition of NeuroMetrix, Inc. (“NeuroMetrix”); first quarter 2025 unaudited Quell net sales of approximately $170,000  Company to host a conference call …

Health Catalyst Reports First Quarter 2025 Results

Health Catalyst Reports First Quarter 2025 Results

SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended …

Clarisil Pro Under Review: Proven Hearing Loss Support Supplement with Secret Navajo Remedy

Clarisil Pro Under Review: Proven Hearing Loss Support Supplement with Secret Navajo Remedy

New York, May 07, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why hearing loss is on the rise—and how environmental and lifestyle factors play a major role The most common causes of auditory decline, including inflammation, nutritional …

Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined

Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined

SAN JOSE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the first …

Sunrun Reports First Quarter 2025 Financial Results

Sunrun Reports First Quarter 2025 Financial Results

Aggregate Subscriber Value of $1.2 billion in Q1, 23% growth year-over-year Contracted Net Value Creation of $164 million, or $0.72 per share, 104% growth year-over-year Cash Generation of $56 million in Q1, the fourth consecutive quarter of positive Cash …

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress

Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this year New non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service